Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer

Lung cancer is the leading cause of cancer deaths worldwide. Most of lung cancer cases are classified as non-small cell lung cancers (NSCLC). EGFR has become an important therapeutic target for the treatment of NSCLC patients, and inhibitors targeting the kinase domain of EGFR are currently used in...

Descripción completa

Detalles Bibliográficos
Autores principales: Eltayeb, Kamal, La Monica, Silvia, Tiseo, Marcello, Alfieri, Roberta, Fumarola, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834094/
https://www.ncbi.nlm.nih.gov/pubmed/35159223
http://dx.doi.org/10.3390/cells11030413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834094/
https://www.ncbi.nlm.nih.gov/pubmed/35159223
http://dx.doi.org/10.3390/cells11030413

Ejemplares similares